Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Diallyl phthalate: Target Organs and Levels of Evidence for TR-242

Carcinogenesis Bioassay of Diallyl Phthalate (CASRN 131-17-9) in B6C3F1 Mice (Gavage Study)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
Diallyl phthalate 131-17-9	06/16/1982	Gavage 0,150,300 MG/KG/50 PER GROUP	Litton Bionetics, Inc.

Levels of Evidence

Male Mice: Equivocal

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Forestomach: SQUAMOUS CELL PAPILLOMA 0/49 1/47 2/49 Hematopoietic System: LYMPHOMA 6/50 5/50 12/50
Non-Neoplastic Lesions	FORESTOMACH: INFLAMMATION, CHRONIC; HYPERPLASIA

Female Mice: Equivocal

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Forestomach: SQUAMOUS CELL PAPILLOMA 0/48 1/47 2/49
Non-Neoplastic Lesions	FORESTOMACH: INFLAMMATION, CHRONIC; HYPERPLASIA